![Shane Hegarty](https://cdn.asp.events/CLIENT_HubXchan_638DBA0F_0C6E_8D3C_A444829FC0C4B73E/sites/HubXChange/media/libraries/experts/Shane-Hegarty-CSO-Axonis-Therapeutics.webp/fit-in/500x500/filters:no_upscale())
![](https://cdn.asp.events/CLIENT_HubXchan_638DBA0F_0C6E_8D3C_A444829FC0C4B73E/sites/HubXChange/media/libraries/experts/Axonis-Therapeutics.png)
Shane Hegarty
CSO,
Axonis Therapeutics
Dr Shane Hegarty is Chief Scientific Officer, Founder and Inventor at AXONIS Therapeutics, Boston-based biotechnology company. 14+ years of experience leading cutting-edge, award-winning neuro-protection, -modulation and -regeneration research for neurological disorders. As Research Fellow in Boston Children’s Hospital/Harvard Medical School, led genome-wide AAV-CRISPR screen for neuro-protection and -regeneration in vivo within Professor Zhigang He’s lab. Before US, he was Faculty Member in Neuroscience Department of University College Cork, Ireland, and received prestigious Neuroscience Ireland Investigator Award. Highly-productive researcher with 30+ publications, >1,400 citations, h-index=18, and serial grant awardee. Experienced entrepreneur, innovator, editor, peer-reviewer, university lecturer, research supervisor, and team manager/mentor.
Sessions